Understanding Transgene's Liquidity Contract Overview
Under the liquidity contract with Natixis Oddo BHF SCA, Transgene has reported on the resources managed as of June 30, 2025. This report sheds light on the company's asset management strategies and market performance.
Key Managed Resources
As of the end of June 2025, the liquidity account held:
- 327,750 shares
- €112,376
Transactions Analysis in H1 2025
In the first half of 2025, Transgene engaged in numerous trades which showcased a considerable activity level:
Purchases and Sales Overview
The purchases and sales for this period were substantial:
| Activity Type | Shares | Value (€) | Market Transactions |
|---|---|---|---|
| Purchases | 249,004 shares | €180,297 | 769 |
| Sales | 280,915 shares | €212,020 | 967 |
Historical Context of Resources
To appreciate the current liquidity management, it's relevant to look back at the historical resources as follows:
- As of December 31, 2024, the liquidity account held:
- 359,661 shares
- €80,653.30
- When the Liquidity Program initiated on January 2, 2020, the account contained:
- 164,183 shares
- €246,158
- The initial resources made available in 2016 were:
- €500,000
Contacts for Investor Relations
Transgene Contact Information:
Lucie Larguier
Chief Financial Officer
Phone: +33 (0)3 88 27 91 00
Email: investorrelations@transgene.fr
Frequently Asked Questions
What is the purpose of Transgene's liquidity contract?
The liquidity contract aims to manage market transactions and stabilize the share price of Transgene.
How many shares were managed as of June 30, 2025?
As of June 30, 2025, there were 327,750 shares managed through the liquidity account.
What were the purchase and sales figures in H1 2025?
Transgene purchased 249,004 shares worth €180,297 and sold 280,915 shares worth €212,020 in the first half of 2025.
How does Transgene's liquidity position compare historically?
The current liquidity position reflects a steady transition from previous years, showcasing growth in resource management.
Who should investors contact for more information?
Investors should contact Lucie Larguier, the CFO, for specific inquiries regarding financial details or concerns.
